S21-113 CDK19-SELECTIVE INHIBITORS, AND METHODS OF USE THEREOF Technology Reference CZ Biohub ref. no. CZB-207S Stanford ref. no. S21-113 Vinnie Alford Mark Smith Michael Clarke Jitendra Gurjar
S19-058 Modulating Bone Morphogenic Protein (BMP) Signaling in the Treatment of Alzheimer's Disease Technology Reference Stanford ref. no S19-058 CZ Biohub ref. no. CZB-179S Researchers at Stanford University have described a novel therapeutic target for Alzheimer's disease. Michael Clarke Jane Antony Maddalena Adorno Felicia Reinitz Benedetta di Robilant Elizabeth Chen
S20-084 CDK19- Selective Inhibitors, and Methods of Use thereof Researchers at Stanford University have identified new CDK19-selective inhibitors for the treatment of triple negative breast cancer. Robert Hsieh Mark Smith Michael Clarke Vinnie Alford Andre St. Amant
S17-013 METHODS FOR TREATING TRIPLE NEGATIVE BREAST CANCER Researchers at Stanford, funded in part by the Chan Zuckerberg Biohub, have developed a method for treating and predicting treatment efficacy of triple negative breast cancer (TNBC). Michael Clarke Robert Hsieh